BL Pharmtech Corp. (KOSDAQ:065170)
1,901.00
-24.00 (-1.25%)
At close: Oct 23, 2026
BL Pharmtech Revenue
BL Pharmtech had revenue of 713.41M KRW in the quarter ending June 30, 2026, a decrease of -60.42%. This brings the company's total for the last twelve months to 3.09B, down -64.20% year-over-year. In the year 2025, BL Pharmtech had annual revenue of 6.51B, down -26.12%. That makes BL Pharmtech the 42,042nd largest company in the world by revenue and 2,556th in South Korea.
Revenue (ttm)
3.09B
Revenue Growth
-64.20%
P/S Ratio
17.17
Revenue / Employee
257.50M
Employees
12
Market Cap
53.06B
Revenue by Segment
- Health Functional Food 5.01B 76.4%
- Other 1.55B 23.6%
Fiscal year ended Dec 31, 2025 See the full BL Pharmtech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.51B | -2.30B | -26.12% |
| Dec 31, 2024 | 8.81B | -15.72B | -64.10% |
| Dec 31, 2023 | 24.53B | 2.00B | 8.89% |
| Dec 31, 2022 | 22.52B | -61.92B | -73.33% |
| Dec 31, 2021 | 84.44B | 18.75B | 28.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Daehan Nupharm | 211.48B |
| RP Bio | 141.42B |
| Jin Yang Pharmaceutical | 124.61B |
| Sinsin Pharmaceutical | 123.05B |
| Hwail Pharmaceutical | 107.87B |
| GeneBioTech Co. ,Ltd | 89.31B |
| Sinil Pharmaceutical | 86.82B |
| Eagle Veterinary Technology Co.,Ltd | 44.73B |